Traded Feb 4 · filed the same day
Derivative exercise or conversion — not an open-market buy.
Traded Jan 8, 2026 · Filed Jan 8, 2026
AAR's Senior VP, GC, CAO & Secretary sold $456K of AAR shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$455,975
Shares × reported transaction price
2 days after results of Jan 6, 2026, 75 days before results of Mar 24, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +8.3% | −0.3% | +8.7% |
| 30 days | +17.8% | 0.0% | +17.9% |
| 90 days | +26.8% | −2.0% | +28.9% |
| 180 days | +37.4% | +7.4% | +30.0% |
Past results only. Not a forecast.
Traded Feb 4 · filed the same day
Derivative exercise or conversion — not an open-market buy.
Traded Feb 4 · filed the same dayNot under a reported trading plan
The CFO of AAR sold $1.17M of AAR shares. The filing does not indicate a pre-arranged trading plan.
Traded Feb 4 · filed the same day
Derivative exercise or conversion — not an open-market buy.